Search research articles
Contact Us
Filters
Showing results (341-350 of 401) with videos related to
Page
of 41
Sort By:
The New England Journal of Medicine
|
March 19, 2019
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D Lopes, Gretchen Heizer, Ronald Aronson, et al.
ESC Heart Failure
|
September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI
David Erlinge, Stefan James, John Deanfield, et al.
European Heart Journal Open
|
June 12, 2025
Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial
Gareth J Williams, Daniel J Taylor, Abdulaziz Al Baraikan, et al.
European Heart Journal
|
October 30, 2016
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
Sigrun Halvorsen, Robert F Storey, Bianca Rocca, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Marco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.
NEJM Evidence
|
February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Stefan James, David Erlinge, Robert F Storey, et al.
Thrombosis and Haemostasis
|
January 10, 2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy
Robert F Storey, Jayaprakash Kotha, Susan S Smyth, et al.
Circulation
|
July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Marco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
American Heart Journal
|
October 23, 2023
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)
Kevin R Bainey, David A Wood, Matthias Bossard, et al.
European Heart Journal
|
July 12, 2015
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Felicita Andreotti, Bianca Rocca, Steen Husted, et al.
Page
of 41
Search research articles
Search
Showing results (341-350 of 401) with videos related to
Sort By:
Page
of 41
The New England Journal of Medicine
|
March 19, 2019
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D Lopes, Gretchen Heizer, Ronald Aronson, et al.
ESC Heart Failure
|
September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI
David Erlinge, Stefan James, John Deanfield, et al.
European Heart Journal Open
|
June 12, 2025
Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial
Gareth J Williams, Daniel J Taylor, Abdulaziz Al Baraikan, et al.
European Heart Journal
|
October 30, 2016
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
Sigrun Halvorsen, Robert F Storey, Bianca Rocca, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Marco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.
NEJM Evidence
|
February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Stefan James, David Erlinge, Robert F Storey, et al.
Thrombosis and Haemostasis
|
January 10, 2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy
Robert F Storey, Jayaprakash Kotha, Susan S Smyth, et al.
Circulation
|
July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Marco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
American Heart Journal
|
October 23, 2023
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)
Kevin R Bainey, David A Wood, Matthias Bossard, et al.
European Heart Journal
|
July 12, 2015
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Felicita Andreotti, Bianca Rocca, Steen Husted, et al.
Page
of 41